placeholder image
A. L. Naleway uri icon qr icon All authors
About me
Publications
selected publications
Journal Article
  • Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19-associated emergency department and urgent care encounters and hospitalizations among nonimmunocompromised children and adolescents aged 5-17 years - VISION Network, 10 states, April 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults - VISION Network, 10 States, December 2021-March 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of a third dose of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during oeriods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults-Nine States, January-September 2021
    American Journal of Transplantation. 2022
  • Evaluation of acute adverse events after Covid-19 vaccination during pregnancy
    New England Journal of Medicine. 2022
  • Monitoring vaccine safety using the vaccine safety Datalink: assessing capacity to integrate data from Immunization Information systems
    Vaccine. 2022
  • Risk of myocarditis and pericarditis following BNT162b2 and mRNA-1273 COVID-19 vaccination
    Vaccine. 2022
  • Safety of COVID-19 vaccination in United States children ages 5 to 11 years
    Pediatrics. 2022
  • Waning 2-dose and 3-dose effectiveness of mRNA vaccines against COVID-19-associated emergency department and urgent care encounters and hospitalizations among adults during periods of Delta and Omicron variant predominance - VISION Network, 10 states, August 2021-January 2022
    MMWR: Morbidity and Mortality Weekly Report. 2022
  • Association of inadvertent 9-valent human papillomavirus vaccine in pregnancy with spontaneous abortion and adverse birth outcomes
    JAMA network open. 2021
  • COVID-19 vaccination coverage among insured persons aged ≥16 years, by race/ethnicity and other selected characteristics - eight integrated health care organizations, United States, December 14, 2020-May 15, 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • COVID-19 vaccination coverage among pregnant women during pregnancy - eight integrated health care organizations, United States, December 14, 2020-May 8, 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Developing algorithms for identifying major structural birth defects using automated electronic health data
    Pharmacoepidemiology and Drug Safety. 2021
  • Effectiveness of 2-dose vaccination with mRNA COVID-19 vaccines against COVID-19-associated hospitalizations among immunocompromised adults - nine states, January-September 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Effectiveness of Covid-19 vaccines in ambulatory and inpatient care settings
    New England Journal of Medicine. 2021
  • Incidence of pediatric inflammatory bowel disease within the Vaccine Safety Datalink network and evaluation of association with rotavirus vaccination
    Vaccine. 2021
  • Interim estimates of COVID-19 vaccine effectiveness against COVID-19-associated emergency department or urgent care clinic encounters and hospitalizations among adults during SARS-CoV-2 B.1.617.2 (Delta) variant predominance - nine states, June-August 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Laboratory-confirmed COVID-19 among adults hospitalized with COVID-19-like illness with infection-induced or mRNA vaccine-induced SARS-CoV-2 immunity - nine states, January-September 2021
    MMWR: Morbidity and Mortality Weekly Report. 2021
  • Spontaneous abortion following COVID-19 vaccination during pregnancy
    JAMA. 2021
  • Surveillance for adverse events after COVID-19 mRNA vaccination
    JAMA. 2021
  • Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination
    Therapeutic advances in drug safety. 2021
  • Evaluating the association of stillbirths after maternal vaccination in the Vaccine Safety Datalink
    Obstetrics and Gynecology. 2020
  • SARS-CoV-2 infection among hospitalized pregnant women: reasons for admission and pregnancy characteristics - eight U.S. health care centers, March 1-May 30, 2020
    MMWR: Morbidity and Mortality Weekly Report. 2020
  • Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders
    Vaccine. 2019
  • Uptake and safety of hepatitis A vaccination during pregnancy: a Vaccine Safety Datalink study
    Vaccine. 2019
  • 2015-2016 Vaccine effectiveness of live attenuated and inactivated influenza vaccines in children in the United States
    Clinical Infectious Diseases. 2018
  • Infant hospitalizations and mortality after maternal vaccination
    Pediatrics. 2018
  • Risk of spontaneous abortion after inadvertent human papillomavirus vaccination in pregnancy
    Obstetrics and Gynecology. 2018
  • The safety of live attenuated influenza vaccine in children and adolescents 2 through 17 years of age: a Vaccine Safety Datalink study
    Pharmacoepidemiology and Drug Safety. 2018
  • Uptake and safety of Hepatitis B vaccination during pregnancy: a Vaccine Safety Datalink study
    Vaccine. 2018
  • Febrile seizure risk after vaccination in children one to five months of age
    Pediatric Neurology. 2017
  • First trimester influenza vaccination and risks for major structural birth defects in offspring
    Journal of Pediatrics. 2017
  • Identifying birth defects in automated data sources in the Vaccine Safety Datalink
    Pharmacoepidemiology and Drug Safety. 2017
  • Live attenuated influenza vaccine use and safety in children and adults with asthma
    Annals of Allergy, Asthma, and Immunology. 2017
  • Maternal Tdap vaccination and risk of infant morbidity
    Vaccine. 2017
  • Maternal and infant outcomes after human papillomavirus vaccination in the periconceptional period or during pregnancy
    Obstetrics and Gynecology. 2017
  • Rates and risk factors associated with hospitalization for pneumonia with ICU admission among adults
    BMC Pulmonary Medicine. 2017
  • Febrile seizure risk after vaccination in children 6 to 23 months
    Pediatrics. 2016
  • Influenza vaccination during pregnancy: influenza seasons 2002-2012, Vaccine Safety Datalink
    American Journal of Preventive Medicine. 2016
  • Maternal Tdap vaccination: coverage and acute safety outcomes in the vaccine safety datalink, 2007-2013
    Vaccine. 2016
  • Risk of preterm or small-for-gestational-age birth after influenza vaccination during pregnancy: caveats when conducting retrospective observational studies
    American Journal of Epidemiology. 2016
  • Association of Tdap vaccination with acute events and adverse birth outcomes among pregnant women with prior tetanus-containing immunizations
    JAMA. 2015
  • Childhood vaccines and Kawasaki disease, Vaccine Safety Datalink, 1996-2006
    Vaccine. 2015
  • Safety of measles-containing vaccines in 1-year-old children
    Pediatrics. 2015
  • Safety of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis and influenza vaccinations in pregnancy
    Obstetrics and Gynecology. 2015
  • Absence of associations between influenza vaccines and increased risks of seizures, Guillain-Barre syndrome, encephalitis, or anaphylaxis in the 2012-2013 season
    Pharmacoepidemiology and Drug Safety. 2014
  • Evaluation of the association of maternal pertussis vaccination with obstetric events and birth outcomes
    JAMA. 2014
  • Monovalent H1N1 influenza vaccine safety in pregnant women, risks for acute adverse events
    Vaccine. 2014
  • Receipt of pertussis vaccine during pregnancy across 7 Vaccine Safety Datalink Sites
    Preventive Medicine. 2014
  • Timely versus delayed early childhood vaccination and seizures
    Pediatrics. 2014
  • Vaccinations given during pregnancy, 2002-2009: a descriptive study
    American Journal of Preventive Medicine. 2014
  • A population-based cohort study of undervaccination in 8 managed care organizations across the United States
    JAMA pediatrics. 2013
  • Association between undervaccination with diphtheria, tetanus toxoids, and acellular pertussis (DTaP) vaccine and risk of pertussis infection in children 3 to 36 months of age
    JAMA pediatrics. 2013
  • Effect of age on the risk of fever and seizures following immunization with measles-containing vaccines in children
    JAMA pediatrics. 2013
  • Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink
    Vaccine. 2013
  • Inactivated influenza vaccine during pregnancy and risks for adverse obstetric events
    Obstetrics and Gynecology. 2013
  • Maternal safety of trivalent inactivated influenza vaccine in pregnant women
    Obstetrics and Gynecology. 2013
  • Mortality rates and cause-of-death patterns in a vaccinated population
    American Journal of Preventive Medicine. 2013
  • Postlicensure surveillance for pre-specified adverse events following the 13-valent pneumococcal conjugate vaccine in children
    Vaccine. 2013
  • Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007-2010
    Pharmacoepidemiology and Drug Safety. 2013
  • Safety of a tetanus-diphtheria-acellular pertussis vaccine when used off-label in an elderly population
    Clinical Infectious Diseases. 2013
  • Safety of the yellow fever vaccine: a retrospective study
    Journal of Travel Medicine. 2013
  • Secular trends in diagnostic code density in electronic healthcare data from health care systems in the Vaccine Safety Datalink Project
    Vaccine. 2013
  • Trivalent inactivated influenza vaccine and spontaneous abortion
    Obstetrics and Gynecology. 2013
  • Vaccination site and risk of local reactions in children 1 through 6 years of age
    Pediatrics. 2013
  • Measles-containing vaccines and febrile seizures in children age 4 to 6 years
    Pediatrics. 2012
  • Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000-2010
    Influenza and other respiratory viruses. 2012
  • H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project
    American Journal of Preventive Medicine. 2011
  • Injection site and risk of medically attended local reactions to acellular pertussis vaccine
    Pediatrics. 2011
  • Monitoring vaccine safety using the Vaccine Safety Datalink: utilizing immunization registries for pandemic influenza
    Vaccine. 2011
  • Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink
    Archives of Pediatrics and Adolescent Medicine. 2011
  • Risk of immune hemolytic anemia in children following immunization
    Vaccine. 2009
  • Varicella vaccination and ischemic stroke in children: is there an association?
    Pediatrics. 2009
  • Contact
    full name
  • A. L. Naleway
  • AL Naleway
  • Quick Info
     
    Collaboration